DHR — Danaher Corporation stock price and chart

DHR

Danaher CorporationStock · HealthcareS&P 500 0.2% · S&P 500 Equal Weight 0.2% · Russell 1000 0.2% · US Stock Market 0.2% · Russell 3000 0.2% · MSCI World 0.1% · MSCI ACWI 0.1%

$200.14-0.19%

as of market close, Sep 11, 2026

☾ AH — —

PeersMRNALLYUNHJNJMRKABBV

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD

20162019202120242026

80.0100.0120.0140.0160.0180.0200.0220.0240.0260.0280.00200.0M400.0M$200.14

2026-09-11

Price$200.14

MA20$190.23

MA50$202.72

Vol18.0M

What would $1,000 invested in DHR be worth today? →

DHR returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $200.14
Change YTD: -12.20%
Next earnings: Oct 20, 2026
Market cap: 140.7B2016-09 48.1B2026-09 140.6B+192.6% over the window
Enterprise value: 164.2B
Shares outstanding: 703M2016-07 690.5M2026-06 703M+1.8% over the window
52W low: $160.93
52W high: $242.80
From 52W high: -17.57%
From 52W low: +24.36%
52W range: 48%
Beta: 0.77

Volume

Rel volume: 1.10×
30D volume: 3.3M
30D $ vol: 683.2M

Fundamentals

Sales (ttm): 25.1B2016-07 16B2026-06 25.1B+56.9% over the window
Sales/share: $35.712016-07 $23.172026-06 $35.71+54.1% over the window
EPS (ttm): $5.632016-07 $5.032026-06 $5.63+12.0% over the window
FCF (ttm): 5.5B2016-07 3.7B2026-06 5.5B+47.5% over the window
FCF/share: $7.782016-07 $5.372026-06 $7.78+44.9% over the window
Book value/share: $74.802016-07 $36.272026-06 $74.80+106.2% over the window
Net margin: 15.95%2016-07 21.9%2026-06 15.9%-27.2% over the window
ROE: 7.61%2016-07 14.0%2026-06 7.6%-45.6% over the window
ROA: 4.33%2016-07 6.8%2026-06 4.3%-36.3% over the window
Debt / equity: 0.48×2016-07 0.482026-06 0.48-0.2% over the window
Current ratio: 1.652016-07 1.402026-06 1.65+18.0% over the window

Growth (CAGR, ttm) · 10Y

Sales: +4.57%2025-06-27 → 2026-06-2624B → 25.1B (+4.6% total)-0.45%2023-06-30 → 2026-06-2625.4B → 25.1B (-1.3% total)-1.24%2021-07-02 → 2026-06-2626.7B → 25.1B (-6.0% total)+4.61%2016-07-01 → 2026-06-2616B → 25.1B (+56.9% total)
Net income: +17.38%2025-06-27 → 2026-06-263.4B → 4B (+17.3% total)-14.34%2023-06-30 → 2026-06-266.4B → 4B (-37.0% total)-6.55%2021-07-02 → 2026-06-265.6B → 4B (-28.6% total)+1.34%2016-07-01 → 2026-06-263.5B → 4B (+14.2% total)
FCF: +12.47%2025-06-27 → 2026-06-264.9B → 5.5B (+12.4% total)-9.04%2023-06-30 → 2026-06-267.3B → 5.5B (-24.7% total)-4.50%2021-07-02 → 2026-06-266.9B → 5.5B (-20.5% total)+3.97%2016-07-01 → 2026-06-263.7B → 5.5B (+47.5% total)
Shares: -1.83%2025-06-27 → 2026-06-26716.1M → 703M (-1.8% total)-1.63%2023-06-30 → 2026-06-26738.4M → 703M (-4.8% total)-0.31%2021-07-02 → 2026-06-26713.9M → 703M (-1.5% total)+0.18%2016-07-01 → 2026-06-26690.5M → 703M (+1.8% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +19.64%2025-06-27 → 2026-06-26$4.71 → $5.63 (+19.6% total)-12.92%2023-06-30 → 2026-06-26$8.52 → $5.63 (-33.9% total)-6.05%2021-07-02 → 2026-06-26$7.69 → $5.63 (-26.7% total)+1.14%2016-07-01 → 2026-06-26$5.03 → $5.63 (+12.0% total)
Sales/share: +6.52%2025-06-27 → 2026-06-26$33.54 → $35.71 (+6.5% total)+1.19%2023-06-30 → 2026-06-26$34.47 → $35.71 (+3.6% total)-0.94%2021-07-02 → 2026-06-26$37.43 → $35.71 (-4.6% total)+4.43%2016-07-01 → 2026-06-26$23.17 → $35.71 (+54.1% total)
FCF/share: +14.57%2025-06-27 → 2026-06-26$6.79 → $7.78 (+14.5% total)-7.54%2023-06-30 → 2026-06-26$9.83 → $7.78 (-20.9% total)-4.21%2021-07-02 → 2026-06-26$9.63 → $7.78 (-19.3% total)+3.78%2016-07-01 → 2026-06-26$5.37 → $7.78 (+44.9% total)
Book value/share: +2.35%2025-06-27 → 2026-06-26$73.09 → $74.80 (+2.3% total)+2.22%2023-06-30 → 2026-06-26$70.04 → $74.80 (+6.8% total)+4.56%2021-07-02 → 2026-06-26$59.89 → $74.80 (+24.9% total)+7.52%2016-07-01 → 2026-06-26$36.27 → $74.80 (+106.2% total)
Dividend/share: +20.71%2025-06-27 → 2026-06-26$1.14 → $1.37 (+20.6% total)+6.92%2023-06-30 → 2026-06-26$1.12 → $1.37 (+22.1% total)+7.21%2021-07-02 → 2026-06-26$0.97 → $1.37 (+41.5% total)+9.26%2016-07-01 → 2026-06-26$0.57 → $1.37 (+142.2% total)
Price: +2.55%2025-09-11 → 2026-09-11$195.16 → $200.14 (+2.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-3.36%2023-09-11 → 2026-09-11$221.78 → $200.14 (-9.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-7.31%2021-09-10 → 2026-09-11$292.54 → $200.14 (-31.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+11.35%2016-09-09 → 2026-09-11$68.28 → $200.14 (+193.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +3.31%2025-09-11 → 2026-09-11$193.73 → $200.14 (+3.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-2.81%2023-09-11 → 2026-09-11$218.04 → $200.14 (-8.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-6.85%2021-09-10 → 2026-09-11$285.49 → $200.14 (-29.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+11.92%2016-09-09 → 2026-09-11$64.88 → $200.14 (+208.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 35.5×2016-09 19.262026-09 35.12+82.3% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 27.4×2016-09 17.982026-09 27.43+52.6% over the window
Fwd P/E: 22.1×
P/S (ttm)Market cap ÷ TTM revenue.: 5.6×2016-09 2.892026-09 5.60+93.7% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 2.7×2016-09 2.072026-09 2.67+29.0% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 25.7×2016-09 13.652026-09 25.73+88.5% over the window
EV/EBITDA (fy): 21.4×
EV/Sales (ttm): 6.5×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 3.88%2016-07 7.7%2026-06 4.1%-47.2% over the window
Dividend yield (fwd)Indicated forward annual dividend ÷ current price — the rate the company has announced, not what was actually paid over the past year.: 0.69%
Dividend/share (fwd): $1.37
Buyback yield (realized, 1y)1 − shares_at(2026-06-26) ÷ shares_at(2025-06-27) = 1 − 703.0M ÷ 716.1M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 1.83%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (1.83%) + dividends paid over that year ($964M) ÷ market_cap_at(2025-06-27) ($142.4B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 2.51%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($2.9B) ÷ today's market cap ($140.7B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 2.06%2016-07 -0.5%2026-06 2.2%-496.0% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $2.9B + TTM dividends $964M) ÷ today's market cap ($140.7B). Same caveat as the cash buyback yield.: 2.75%2016-07 0.3%2026-06 2.9%+975.0% over the window

Vs own 10Y history

P/E: 62nd
P/OI: 47th
P/S: 40th
P/B: 33rd
P/FCF: 54th

Bar = where today’s multiple sits in DHR’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · windows as of 2026-09-11

-0.19%

-5.16%

-2.75%

+10.93%

YTD

-12.20%

+4.69%

-30.20%

Financial statements

Open full DHR financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	-8.44%	-0.65%
JNJ	Johnson & Johnson	+2.31%	-0.29%
ABBV	AbbVie Inc.	+3.36%	+0.83%
MRK	Merck & Co. Inc.	+8.28%	-0.54%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	-6.53%	-2.37%
TMO	Thermo Fisher Scientific Inc.	+1.13%	+1.10%
AMGN	Amgen Inc.	-8.80%	-1.34%
GILD	Gilead Sciences Inc.	+5.78%	-0.75%

Danaher Corporation (DHR) trades at $200.14 with a live price and an interactive chart covering 47+ years of daily price history, plus key valuation metrics. ChartRow also publishes DHR’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full DHR financial statements →

DHR — Danaher Corporation price, chart and key statistics